JIE MENG | Neuroscience | Best Researcher Award

Dr. JIE MENG | Neuroscience | Best Researcher AwardĀ šŸ†

Assistant Professor at Sichuan University, China.

Dr. Jie Meng is an Assistant Professor at Sichuan University, China. With expertise in [specific field, e.g., molecular biology, environmental science, engineering], Dr. Meng has contributed significantly to both research and teaching. His work focuses onDr. Meng has published [number] papers in reputed journals and actively participates in academic conferences. He is committed to advancing knowledge in his field while fostering a collaborative learning environment for students at Sichuan University.

Profile

ORCID

Scopus

Education šŸŽ“:

Jie Meng holds a Ph.D. in Neuroscience from Kyushu University, Japan, completed in 2019. This advanced education provided a solid foundation in understanding the intricate mechanisms underlying neurodegenerative diseases.

Work Experience šŸ’¼:

Jie Meng is currently an Intermediate Researcher at Sichuan University West China Hospital in Chengdu, China, a position held since 2019. In this role, Jie Meng conducts cutting-edge research into neurodegenerative diseases, focusing particularly on Alzheimer’s disease and Parkinson’s disease.

Awards and Honors

Jie Meng’s exceptional contributions to the field of neuroscience have been recognized with several awards, including the Qinghai Province Science and Technology Award, where he received the Second Prize in Natural Science for his innovative work in neurodegeneration research.

Research Interests:

Jie Meng’s research primarily revolves around the mechanisms of neurodegenerative diseases, with a strong emphasis on microglia-mediated neuroinflammation in Alzheimer’s disease (AD). His work seeks to identify novel epigenetic biomarkers for early-onset Parkinson’s disease (PD) and explore therapeutic strategies aimed at mitigating chronic neuroinflammation.,Investigating the role of microglia in neuroinflammation and how it contributes to AD progression.,Exploring epigenetic biomarkers that can aid in the early detection of Parkinson’s disease.,Developing innovative therapeutic approaches to target chronic neuroinflammation in neurodegenerative disorders.

šŸ“š PublicationĀ 

  • Testing cognitive normal for Alzheimer’s disease prediction
    Citations: 0
    Year: 2025
    Authors: Meng, J., Lei, P.
    Journal: Journal of Neurochemistry

 

  • Iron promotes both ferroptosis and necroptosis in the early stage of reperfusion in ischemic stroke
    Citations: 2
    Year: 2024
    Authors: Du, B., Deng, Z., Chen, K., Tuo, Q.-Z., Lei, P.
    Journal: Genes and Diseases

 

 

  • How brain ā€˜cleaners’ fail: Mechanisms and therapeutic value of microglial phagocytosis in Alzheimer’s disease
    Citations: 12
    Year: 2024
    Authors: Ni, J., Xie, Z., Quan, Z., Meng, J., Qing, H.
    Journal: GLIA

 

  • Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway
    Citations: 5
    Year: 2024
    Authors: Xu, S., Tuo, Q.-Z., Meng, J., Li, C.-L., Lei, P.
    Journal: Translational Oncology

 

 

  • Leucine-rich repeat kinase 2 (LRRK2) inhibition upregulates microtubule-associated protein 1B to ameliorate lysosomal dysfunction and parkinsonism
    Citations: 3
    Year: 2023
    Authors: Chen, K., Tang, F., Du, B., Lei, P., Wei, X.-W.
    Journal: MedComm

 

  • The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
    Citations: 8
    Year: 2023
    Authors: Xie, Z., Meng, J., Wu, Z., Qing, H., Ni, J.
    Journal: Neuroscientist

 

  • Scopolamine causes delirium-like brain network dysfunction and reversible cognitive impairment without neuronal loss
    Citations: 8
    Year: 2023
    Authors: Wang, Q., Zhang, X., Guo, Y.-J., Yue, J.-R., Lei, P.
    Journal: Zoological Research

 

  • Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer’s disease
    Citations: 14
    Year: 2022
    Authors: Xie, Z., Meng, J., Kong, W., Qing, H., Ni, J.
    Journal: Aging Cell

 

  • Differential Expression and Distinct Roles of Proteinase-Activated Receptor 2 in Microglia and Neurons in Neonatal Mouse Brain After Hypoxia-Ischemic Injury
    Citations: 6
    Year: 2022
    Authors: Liu, Y., Li, H., Hu, J., Qing, H., Ni, J.
    Journal: Molecular Neurobiology

 

  • Nucleus distribution of cathepsin B in senescent microglia promotes brain aging through degradation of sirtuins
    Citations: 28
    Year: 2020
    Authors: Meng, J., Liu, Y., Xie, Z., Lei, P., Ni, J.
    Journal: Neurobiology of Aging

 

ConclusionĀ 

In conclusion, to fully assess Dr. Jie Meng’s suitability for the Best Researcher Award, one would need to gather detailed information on their research outputs, contributions to the field, collaborations, and overall recognition. If their work aligns with the criteria outlined above, Dr. Meng could very well be a strong contender for the award. Additionally, providing more details on their specific research achievements would allow for a more tailored evaluation and clearer recommendations for areas where they could continue to excel.

 

Luisa Pozzo | Neuroscience | Best Paper Award

Dr. Luisa Pozzo | Neuroscience | Best Paper Award Ā Ā šŸ†

Researcher at IBBA-CNR, Italy

Dr. Luisa Pozzo is a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA) since 2011. She holds a degree in Veterinary Medicine from the University of Turin (2007) and a PhD in Veterinary Sciences (2011) from the same university. Dr. Pozzo also earned a Master’s degree in Food Science from the University of Pisa (2013). Her research focuses on the bio-functional characterization of food products, particularly their role in managing inflammation and oxidative stress in chronic degenerative diseases like diabetes and cardiovascular issues. She has worked internationally in France, Poland, and Spain and currently holds a teaching position at the University of Pisa. With an H-index of 17 and over 663 citations, Dr. Pozzo has made significant contributions to the fields of food science, nutraceuticals, and health research.

Profile

SCOPUS

ORCID

Education šŸŽ“:

Dr. Luisa Pozzo completed her education with a strong focus on veterinary medicine and food science. She graduated in 2007 with a degree in Veterinary Medicine from the University of Turin. Following this, she pursued advanced studies and earned her PhD in Veterinary Sciences (XXIII cycle) from the same university in 2011. Further expanding her expertise, she obtained a 2nd level Master’s degree in “Food Science: quality, safety and human nutrition” from the University of Pisa in 2013. Dr. Pozzo also gained international experience during her PhD training at the Mycotoxicology Unit of the ENVT in France in 2010. This educational background has provided her with a robust foundation in both veterinary science and food-related research, fueling her work in areas like food bio-functionality and chronic disease prevention.

Work Experience šŸ’¼:

Dr. Luisa Pozzo has extensive research and teaching experience in the fields of veterinary medicine, food science, and nutrition. Since 2011, she has been a Researcher at the Institute of Agricultural Biology and Biotechnology of the National Research Council (CNR-IBBA), where she focuses on the bio-functional properties of food products in relation to chronic diseases. Her international experience includes a PhD training at the Mycotoxicology Unit at ENVT in France (2010), and research roles as a Host Researcher at the Institute of Animal Reproduction and Food Research in Poland (2015) and IATA CSIC in Spain (2018). Since 2016, Dr. Pozzo has been a university lecturer at the University of Pisa, teaching Applied Nutraceuticals in the Human Nutrition Sciences program. Additionally, she has served as a Section Editor for the Polish Journal of Food and Nutrition Sciences since 2019 and has been a technical-scientific expert for the Italian Ministry of Economic Development. Her work has contributed to advancing the understanding of food’s role in health, with particular emphasis on antimicrobial and prebiotic effects.

Skills šŸ”

Dr. Luisa Pozzo possesses a diverse skill set spanning veterinary medicine, food science, and nutrition research. Her expertise includes the bio-functional characterization of food products, with a focus on their role in preventing inflammation and oxidative stress associated with chronic degenerative diseases such as diabetes, cardiovascular diseases, and neurodegenerative disorders. She is skilled in using in vivo models (mice and rats) for testing the interactions between food products and drug metabolism. Additionally, Dr. Pozzo has expertise in antimicrobial and prebiotic effects of food products and bioactive compounds through in vitro testing. Her strong academic background and international research experience have equipped her with advanced skills in scientific communication, project evaluation, and academic mentorship, particularly in the fields of applied nutraceuticals and human nutrition.

Awards and Honors šŸ†

Dr. Luisa Pozzo has received notable recognition for her contributions to the fields of food science and nutrition. In addition to her academic achievements, she has been acknowledged for her role as a Section Editor for the Polish Journal of Food and Nutrition Sciences (PJFNS) since 2019, where she contributes to advancing nutritional research. Her expertise has also been sought by the Italian Ministry of Economic Development (MiSE), where she has served as a technical-scientific expert for the evaluation of research projects under the Fund for Sustainable Growth. Furthermore, Dr. Pozzo’s dedication to international academic collaboration was recognized through a Staff Mobility for Teaching Assignments (STA) under the Erasmus+ Mobility Program in 2022, further cementing her standing in the global scientific community.

Research Interests:

Dr. Luisa Pozzo’s research interests center around the bio-functional characterization of food products, focusing on their protective roles in combating inflammation and oxidative stress associated with chronic degenerative diseases, including diabetes, cardiovascular diseases, neurodegenerative diseases, and chronic respiratory conditions. She is particularly interested in understanding the interactions between food products, bioactive compounds, and drug metabolism, using in vivo models (mice and rats) to explore these effects. Additionally, Dr. Pozzo investigates the antimicrobial and prebiotic properties of food products, seeking to identify potential health benefits and applications in disease prevention and management. Her research aims to contribute to the development of nutraceutical strategies for improving public health.

šŸ“š PublicationsĀ 

  • Title: Probing the Alterations in Mice Cecal Content Due to High-Fat Diet
    • Authors: Trouki, C., Campanella, B., Onor, M., Longo, V., Bramanti, E.
    • Journal: Food Chemistry
    • Year: 2024
    • Volume/Issue: 455, 139856
    • Citations: 0
  • Title: Assessment of the Antioxidant and Hypolipidemic Properties of Salicornia europaea for the Prevention of TAFLD in Rats
    • Authors: Souid, A., Giambastiani, L., Castagna, A., Pozzo, L., Vornoli, A.
    • Journal: Antioxidants
    • Year: 2024
    • Volume/Issue: 13(5), 596
    • Citations: 3
  • Title: Characterization and Stability Evaluation of Egyptian Propolis Extract Nano-Capsules and Their Application
    • Authors: Amin, A.A., Mahmoud, K.F., Salama, M.F., Seliem, E.I., Ibrahim, M.A.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume/Issue: 13(1), 16065
    • Citations: 2
  • Title: Chlamydomonas agloeformis from the Ecuadorian Highlands: Nutrients and Bioactive Compounds Profiling and In Vitro Antioxidant Activity
    • Authors: Grande, T., Vornoli, A., Lubrano, V., Echeverria, M.C., Pozzo, L.
    • Journal: Foods
    • Year: 2023
    • Volume/Issue: 12(17), 3147
    • Citations: 4
  • Title: Characterization of Antioxidant and Antimicrobial Activity and Phenolic Compound Profile of Extracts from Seeds of Different Vitis Species
    • Authors: Pozzo, L., Grande, T., Raffaelli, A., Amarowicz, R., Karamać, M.
    • Journal: Molecules
    • Year: 2023
    • Volume/Issue: 28(13), 4924
    • Citations: 9
  • Title: In Vitro Characterization of Antioxidant, Antibacterial, and Antimutagenic Activities of the Green Microalga Ettlia pseudoalveolaris
    • Authors: Vornoli, A., Grande, T., Lubrano, V., Pozzo, L., Echeverria, C.
    • Journal: Antioxidants
    • Year: 2023
    • Volume/Issue: 12(6), 1308
    • Citations: 5

ConclusionĀ 

Given Dr. Luisa Pozzo’s extensive research on the bio-functional roles of food in chronic disease prevention, her strong academic credentials, and her contributions to the field of nutraceuticals, she is a highly suitable candidate for the Research for Best Paper Award. Her research not only enhances our understanding of food’s potential to improve health but also paves the way for innovative solutions to combat chronic diseases.

 

 

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research

Prof. Jiaxing Zhang | Cognitive Neuroscience | Excellence in Research šŸ†

Professor at Xiamen University,China šŸŽ“

Dr. Jiaxing Zhang is a distinguished Professor at Xiamen University, specializing in brain hypoxia and its effects on cognitive function and emotions. His research focuses on how the brain adapts and remodels to hypoxia and reoxygenation, exploring neural mechanisms and compensatory regulatory functions in hypoxic conditions. Using advanced techniques such as MRI, molecular biology, and cognitive behavioral testing, Dr. Zhang conducts both human and animal model studies to explore how the brain and cardiovascular systems respond to oxygen deprivation and recovery.

Professional ProfileĀ 

Education šŸŽ“:

Dr. Zhang completed his academic training in neuroscience and brain science, earning a Ph.D. that laid the foundation for his pioneering work on brain hypoxia and adaptation mechanisms.

Work Experience šŸ’¼:

He is currently a professor at Xiamen University, where he leads research projects focused on brain adaptation to hypoxia, collaborating internationally with other researchers in the field.

Skills šŸ”

Dr. Zhang is proficient in advanced research methods, including magnetic resonance imaging (MRI), molecular biology, and cognitive behavioral testing. He also possesses strong interdisciplinary skills in neuroscience and bioengineering.

Awards and Honors šŸ†

Dr. Zhang has received numerous recognitions for his scientific contributions, including the Distinguished Scientist Award, which highlights his impactful research on brain adaptation to high-altitude environments.

šŸ¤ Memberships:

He is an active member of various professional scientific communities, contributing to advancements in brain science and hypoxia research.

Teaching Experience šŸ‘©ā€šŸ«:

Dr. Zhang has extensive teaching experience, mentoring students and guiding research projects in brain science, neuroscience, and hypoxia adaptation.

Research Focus šŸ”¬:

Dr. Zhang’s research primarily focuses on brain hypoxia and its effects on cognitive function, with a particular interest in high-altitude adaptation. His work provides critical insights into how the brain responds to low-oxygen environments and how these mechanisms can inform health interventions.

ConclusionĀ 

Dr. Fatemeh Rezaei is a highly qualified candidate for the Outstanding Scientist Award. Her achievements in laser and plasma research, especially in laser-based medical applications, position her as a forward-thinking and impactful scientist. With a strong foundation in both education and research, along with meaningful contributions to science and society, Dr. Rezaei exemplifies the qualities of an outstanding scientist. Expanding her publication record and enhancing international collaborations would further amplify her research impact, making her an exceptional choice for this award.

šŸ“š PublilcationĀ 

    1. Correlating EPAS1 gene variations to hypoxic environments with structural and functional brain network adaptations of Tibetans in the Qinghai-Xizang Plateau
      • Year: 2024
      • Journal: Kexue Tongbao/Chinese Science Bulletin
      • Authors: Liu, Y., Fan, C., Zhang, X., Wang, X., Zhang, J.
    2. A longitudinal study on the impact of high-altitude hypoxia on perceptual processes
      • Year: 2024
      • Journal: Psychophysiology
      • Authors: Guo, F., Wang, C., Tao, G., Zhang, J., Wang, Y.
    3. Neuroplasticity of visual brain network induced by hypoxia
      • Year: 2024
      • Journal: Cerebral Cortex
      • Authors: Zhang, X., Liu, Y., Yuan, F., Wang, X., Zhang, J.
    4. Decrease in Cerebral Blood Flow after Reoxygenation Is Associated with Neurological Syndrome Sequelae and Blood Pressure
      • Year: 2023
      • Journal: Brain Sciences
      • Authors: Liu, Y., Yuan, F., Peng, Z., Zhang, R., Zhang, J.
    5. The change of attention network functions and physiological adaptation during high-altitude hypoxia and reoxygenation
      • Year: 2023
      • Journal: Physiology and Behavior
      • Authors: Song, R., Tao, G., Guo, F., Zhang, J., Wang, Y.
    6. Hypoxic White Matter Injury and Recovery After Reoxygenation in Adult Mice: Magnetic Resonance Imaging Findings and Histological Studies
      • Year: 2023
      • Journal: Cellular and Molecular Neurobiology
      • Authors: Liu, Y., Qiao, H., Du, W., Li, S., Zhang, J.
    7. Brain Structural and Functional Alterations in Native Tibetans Living at High Altitude
      • Year: 2023
      • Journal: Neuroscience
      • Authors: Zhang, X., Xie, W., Liu, Y., Ma, H., Zhang, J.
    8. Consistent differences in brain structure and functional connectivity in high-altitude native Tibetans and immigrants
      • Year: 2023
      • Journal: Brain Imaging and Behavior
      • Authors: Zhang, X., Xie, W., Du, W., Ma, H., Zhang, J.
    9. The human brain in a high altitude natural environment: A review
      • Year: 2022
      • Journal: Frontiers in Human Neuroscience
      • Authors: Zhang, X., Zhang, J.
    10. Resting‐State Neuronal Activity and Functional Connectivity Changes in the Visual Cortex after High Altitude Exposure: A Longitudinal Study
    • Year: 2022
    • Journal: Brain Sciences
    • Authors: Zhang, X., Kang, T., Liu, Y., Lin, J., Zhang, J.

Prof. Dr. binli | Neuroscience | Best Researcher Award

Prof. Dr. binli | Neuroscience | Best Researcher Award šŸ†

Lecturer (University Professor) at yangzhou university,ChinašŸŽ“

The nominee, a PhD holder in Architecture since 2016, has demonstrated excellence in research, education, and practical applications in architecture and sustainability. His dual focus on comfort and accessibility, alongside nature-based solutions for climate resilience, addresses critical contemporary issues. His notable contributions, backed by research grants and real-world projects, underscore his commitment to advancing sustainable architecture.

 

Professional ProfileĀ 

šŸŽ“ Education

Bin Li earned his Ph.D. in Neuroscience from Nanjing Agricultural University, where his master’s thesis was recognized as an excellent thesis. His educational background laid a strong foundation for his expertise in neuroimmunology and endothelial cell research. šŸŽ“šŸ†

šŸ¢ Work Experience

As a university-appointed professor, Bin has made significant contributions to the field of Neuroscience. His work focuses on the mechanisms of mRNA methylation in endothelial cells and their role in recovery after ischemic stroke, enhancing our understanding of neurovascular repair processes. šŸ§ šŸ„

🧬 Skills

  • Bin possesses advanced research skills in molecular biology and neuroimmunology, with a strong capability in conducting complex experiments and data analysis. His ability to communicate complex scientific concepts effectively enhances his teaching and mentorship roles. šŸ§ŖšŸ“Š

Awards and Honors šŸ†

He has received numerous accolades, including the “Lv Yang Jin Feng” Outstanding Doctor award and recognition for an outstanding paper at the 19th National Academic Exchange Meeting on Neuropsychopharmacology in 2021. šŸ„‡šŸŽ–ļø

MembershipsšŸ“œĀ 

Bin is an active member of professional organizations, including the Neuroimmunology Branch of the Jiangsu Society of Immunology and the Basic Veterinary Branch of the Jiangsu Animal Husbandry and Veterinary Association, which facilitate collaboration and knowledge exchange in his field. šŸ¤šŸŒ

šŸ“š Teaching Experience

In his role as a lecturer, Bin is dedicated to educating the next generation of scientists, fostering a stimulating learning environment, and guiding students through advanced concepts in Neuroscience and immunology. šŸ“–šŸ‘Øā€šŸ«

šŸ”¬ Research Focus

His current research investigates glial cell-to-neuron and endothelial cell inter-communication during post-ischemic injury, aiming to uncover novel therapeutic strategies for brain recovery. With a total of 12 published papers and significant citations, his research is influential in the field. šŸ”šŸ§¬

ConclusionĀ 

In conclusion, Dr. Bin Li exemplifies the qualities of a leading researcher deserving of the Best Researcher Award. His innovative research, impressive publication record, and active engagement in the scientific community highlight his significant contributions to neuroscience. Addressing the areas for improvement could further amplify his impact, making him a valuable asset to both academia and society. Dr. Li’s commitment to advancing knowledge in neurovascular repair positions him as an outstanding candidate for this prestigious recognition.

šŸ“š PublilcationĀ 

  • EHR coding with hybrid attention and features propagation on disease knowledge graph
    • Year: 2024
    • Journal: Artificial Intelligence in Medicine
  • DAJLENet: A neural network based on dual attention and joint learning for explainable heart failure adverse event prediction
    • Year: 2024
    • Journal: Computers and Electrical Engineering
  • Application programming interface recommendation for smart contract using deep learning from augmented code representation
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process
  • Extraction of Corn Plant Phenotypic Parameters with Keypoint Detection and Stereo Images
    • Year: 2024
    • Journal: Agronomy
  • Ponzi Scheme Detection in Smart Contract via Transaction Semantic Representation Learning
    • Year: 2024
    • Journal: IEEE Transactions on Reliability
  • Normalization of kinship relations to enrich family network analysis: case study on China biographical database
    • Year: 2024
    • Journal: Digital Scholarship in the Humanities
  • Fine-grained smart contract vulnerability detection by heterogeneous code feature learning and automated dataset construction
    • Year: 2024
    • Journal: Journal of Systems and Software
  • Neurodynamics for Equality-Constrained Time-Variant Nonlinear Optimization Using Discretization
    • Year: 2024
    • Journal: IEEE Transactions on Industrial Informatics
  • Automatic software vulnerability classification by extracting vulnerability triggers
    • Year: 2024
    • Journal: Journal of Software: Evolution and Process

 

 

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

Prof Dr Ryszard Pluta | Neuroscience | Best Researcher Award

MD.,PhD at Ā Medical University of Lublin , Poland

Dr. Ryszard Pluta is a distinguished neurologist and neuroscientist, with a medical degree from the Medical Academy in Lublin (1977) and a Ph.D. from the Polish Academy of Sciences (1983). He has served as a Professor at the Mossakowski Medical Research Institute and held prestigious postdoctoral fellowships at the NIH and NYS Institute for Basic Research. A recognized expert in brain ischemia and Alzheimer’s disease, Dr. Pluta has published extensively, including multiple influential books on the subject. He is a recipient of numerous awards and is an active member of several professional societies. His significant contributions to understanding the links between ischemia and Alzheimer’s have established him as a leading figure in neuropathology.

Profile:

ScopusĀ 

Education šŸŽ“

Ryszard Pluta earned his medical degree from the Medical Academy in Lublin (1971-1977) and attended Humboldt University in Berlin (1975) and the University of Cologne (1976). He completed his Ph.D. at the Polish Academy of Sciences in Warsaw (1983). He became an Associated Professor in 1992 and a full Professor in 2004 at the Mossakowski Medical Research Institute, Polish Academy of Sciences.

Work Experience šŸ’¼

Dr. Pluta has held prestigious positions, including postdoctoral fellowships at the NIH in Bethesda, USA (1986-1988), and the NYS Institute for Basic Research in New York (1988-1989). He has been a Visiting Professor at several renowned institutions, including the Max-Planck Institute for Neurological Research and Charles University in Prague.

Skills 🧠

With extensive expertise in neuropathology and neurochemistry, Dr. Pluta specializes in brain ischemia and Alzheimer’s disease research. His skills encompass project management, collaboration with international research teams, and contributions to clinical studies in the field of neuroscience.

Awards and Honors šŸ†

Dr. Pluta has received numerous accolades, including recognition from the Polish Association of Neuropathologists (1980, 1986) and the Polish Academy of Sciences (1982, 1989, 1992). He was also honored by the International Brain Research Organization (1997) and the Alzheimer’s Association in Chicago (1998).

Membership šŸ¤

He is an active member of various professional organizations, including the Polish Association of Neuropathologists and the International Society of Neuropathology. Dr. Pluta is recognized among the World’s Top 2% scientists by Stanford University.

Teaching Experience šŸ“š

Dr. Pluta has contributed to the academic community through teaching positions at various universities, where he has shared his knowledge and expertise in neuropathology and neuroscience with students and researchers.

Research Focus šŸ”¬

His research focuses on brain ischemia, its relationship with Alzheimer’s disease, and associated neuropathological changes. He has made significant contributions, such as the documentation of identical changes in ischemic brains and those affected by Alzheimer’s, and the exploration of potential therapeutic approaches involving β-amyloid peptide.

 

Publications:

  • Alpha-, Beta-, and Gamma-Secretase, Amyloid Precursor Protein, and Tau Protein Genes in the Hippocampal CA3 Subfield in an Ischemic Model of Alzheimer’s Disease with Survival up to 2 Years
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Trans- and Cis-Phosphorylated Tau Protein: New Pieces of the Puzzle in the Development of Neurofibrillary Tangles in Post-Ischemic Brain Neurodegeneration of the Alzheimer’s Disease-like Type
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • A Look at the Etiology of Alzheimer’s Disease based on the Brain Ischemia Model
    • Year: 2024
    • Journal: Current Alzheimer Research
  • Apoptosis, Autophagy, and Mitophagy Genes in the CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2024
    • Journal: Journal of Alzheimer’s Disease
  • Ischemia-Reperfusion Programming of Alzheimer’s Disease-Related Genes—A New Perspective on Brain Neurodegeneration after Cardiac Arrest
    • Year: 2024
    • Journal: International Journal of Molecular Sciences
  • LRP1 and RAGE Genes Transporting Amyloid and Tau Protein in the Hippocampal CA3 Area in an Ischemic Model of Alzheimer’s Disease with 2-Year Survival
    • Year: 2023
    • Journal: Cells
  • The Dual Role of Autophagy in Postischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Preservation of Biomarkers Associated with Alzheimer’s Disease (Amyloid Peptides 1-38, 1-40, 1-42, Tau Protein, Beclin 1) in the Blood of Neonates after Perinatal Asphyxia
    • Year: 2023
    • Journal: International Journal of Molecular Sciences
  • Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer’s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids
    • Year: 2023
    • Journal: Molecules
  • Post-Ischemic Permeability of the Blood–Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer’s Disease-Type Brain Neurodegeneration
    • Year: 2023
    • Journal: International Journal of Molecular Sciences

Dr. Amira Boseila | Neuroscience| Best Researcher Award

Dr. Amira Boseila | Neuroscience| Best Researcher AwardšŸ†


Lecturer at Sinai University,EgyptšŸŽ“

Dr. Amira Abdel Halim Hamada Boseila is a full-time lecturer in Pharmaceutical Sciences at Sinai University, Egypt, where she teaches advanced courses in drug delivery systems and pharmaceutics. She also serves as a post-doctoral researcher at the National Organization for Drug Control and Research (NODCAR) and the Egyptian Drug Authority. With a PhD from Cairo University, her research focuses on nanomedicine, drug targeting, and innovative drug delivery systems. Dr. Boseila has contributed to several impactful publications and is actively involved in various research projects aimed at enhancing therapeutic strategies.

 

Professional ProfileĀ 

šŸŽ“ Education

Dr. Amira Abdel Halim Hamada Boseila holds a Doctor of Philosophy in Pharmaceutical Sciences from the Faculty of Pharmacy at Cairo University, awarded in February 2020, with a thesis focused on the utility of nanocarriers for targeted delivery of an antiviral drug to the liver. She also earned a Master of Pharmaceutical Sciences from Cairo University in December 2013, where her thesis was centered on the formulation and evaluation of a modified nasal drug delivery system for the antiemetic drug ondansetron. Additionally, she completed a Total Quality Management Diploma at the American University of Cairo in 2009, further enhancing her expertise in quality control management. Her academic journey began with a Bachelor of Pharmaceutical Sciences from Cairo University, graduating in May 2007 with a grade of very good. She attended La Rose De Lisieux/Language School in Dokkie, where she completed her high school education with a focus on science from September 1990 to June 2002.

 

šŸ¢ Work Experience

Full-time lecturer at the Faculty of Pharmacy, Sinai University since September 2022, and post-doctoral researcher at NODCAR and the Egyptian Drug Authority since July 2020. Previously held positions as lead quality control specialist and head of the Comparative Dissolution Unit. Guest lecturer on drug targeting at Ain Shams University since October 2020

🧬 Skills

Expertise in novel drug delivery systems, nanomedicine, drug targeting, pharmacokinetics, comparative dissolution studies, and quality by design

Awards and Honors šŸ†

Recognized for contributions to pharmaceutical research through impactful publications and ongoing collaborations with prestigious institutions, including funded research projects from the University of Hail and Misr El Kheir Foundation

šŸ”¬ Research Focus

Dedicated to advancing nanomedicine and innovative drug delivery systems, with a focus on developing targeted therapies and modified release dosage forms. Actively involved in projects aimed at repurposing anti-inflammatory agents and formulating virucidal throat sprays

šŸ“š PublicationĀ 

  • Impact of Lyophilized Milk Kefir-Based Self-Nanoemulsifying System on Cognitive Enhancement via the Microbiota–Gut–Brain Axis
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Throat Spray Formulated with Virucidal Pharmaceutical Excipients as an Effective Early Prophylactic or Treatment Strategy Against Pharyngitis Post-Exposure to SARS-CoV-2
    Author: Amira Boseila
    Citation: ScienceDirect, 2024
  • Antidepressive and Cardioprotective Effects of Self-Nanoemulsifying Self-Nanosuspension Loaded with Hypericum Perforatum on Post-Myocardial Infarction Depression in Rats
    Author: Amira Boseila
    Citation: Springer, 2022
  • Recent Advances in Adsorptive Nanocomposite Membranes for Heavy Metals Ion Removal from Contaminated Water: A Comprehensive Review
    Author: Amira Boseila
    Citation: MDPI, 2023
  • Iron Oxide Nanoparticles-Plant Insignia Synthesis with Favorable Biomedical Activities and Less Toxicity, in the ā€œEra of the-Greenā€: A Systematic Review
    Author: Amira Boseila
    Citation: NIH, 2023
  • In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Superiority of DEAE-Dx-Stabilized Cationic Bile-Based Vesicles over Conventional Vesicles for Enhanced Hepatic Delivery of Daclatasvir
    Author: Amira Boseila
    Citation: Molecular Pharmaceutics, 2023
  • Design of Bile-Based Vesicles (BBVs) for Hepatocytes Specific Delivery of Daclatasvir: Comparison of Ex-Vivo Transenterocytic Transport, In-Vitro Protein Adsorption Resistance, and HepG2 Cellular Uptake of Charged and β-Sitosterol Decorated Vesicles
    Author: Amira Boseila
    Citation: PubMed, 2023
  • Preparation and Characterization of Thermosensitive Mucoadhesive In-Situ Gels for Nasal Delivery of Ondansetron Hydrochloride
    Authors: A.A. Boseila, A.Y. Abdel-Reheem, G. Abdelbary
    Citation: Al-Azhar Journal of Pharmaceutical Sciences, 2014

 

Dr NISHI PATEL | Neuroscience | Best Researcher Award

Dr NISHI PATEL | Neuroscience | Best Researcher AwardĀ Ā  šŸ†

Research Scholar at Bhagwan Mahavir University, Surat , IndiašŸŽ“

Dr. Nishi Jayesh Patel is a dedicated research scholar at Bhagwan Mahavir University, specializing in the study of Parkinson’s Disease 🧠. With over four years of significant contributions in this field, she has become an expert in neurodegenerative disorders, particularly focusing on microbiology and probiotics. Dr. Patel has published research on the relationship between gut microflora and Parkinson’s, exploring innovative treatments such as in-vitro probiotic formulations. She is also a member of the Parkinson’s Foundation, continually striving to advance knowledge and treatment for the disease.

 

Professional ProfileĀ 

  • Google ScholarĀ 

Education šŸŽ“

Dr. Patel holds advanced degrees in microbiology and neurological sciences, fueling her passion for neurodegenerative disease research. Her academic excellence and thorough understanding of Parkinson’s Disease enable her to make meaningful strides in the field.

Work Experience šŸ¢

Apart from her research work, Dr. Patel is a seasoned subject matter expert and has contributed significantly to academic assessment by setting papers for national and international entrance exams. Her work in this area has helped shape the academic landscape and ensure high standards for future medical professionals.

Awards and Honors šŸ†

While specific awards are not mentioned, Dr. Patel’sĀ numerous professional contributions, including her membership in the Parkinson’s Foundation, speak to her dedication and excellence in the field of medical research.

Research Focus šŸ”

Dr. Patel’s core research focuses on probiotics and their role in neurological disorders. She has identified six bacterial strains that are potential candidates for therapeutic use in Parkinson’s Disease, with promising results in balancing GABA collapse, improving drug bioavailability, and controlling disease progression. These isolates show potential in controlling mood, immunity, and digestion, positively influencing patients’ well-being.

 

 

Publications :Ā 

  • Evaluating Probiotic Properties of Gut Microflora for Gut Modulation as an Adjuvant Therapy for Parkinson’s Disease
    Authors: NJ Patel, M Hajoori
    Journal: Journal of Future Foods
    Year: 2025
    Volume: 5
    Issue: 3
    Pages: 304-316
  • Isolation, Characterisation, and Screening of Gut Bacteria for Essential Probiotic Characteristics
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: European Journal of Biomedical and Pharmaceutical Sciences
    Year: 2023
    Volume: 10
    Issue: 11
    Pages: 176-179
  • Comparative Formulation and Evaluation of Probiotic Products Utilizing Different Bacterial Strains: A Comprehensive Study
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Biological Forum – An International Journal
    Year: 2023
    Volume: 15
    Issue: 5
    Pages: 1747-1752
  • Psychobiotics: The Next Generation Adjuvant Therapy and Its Revolutionary Contribution in Treatment for Parkinson’s Disease
    Authors: DPD Nishi Jayesh Patel, Dr. Murtaza Hajoori
    Journal: Futuristic Trends in Medical Sciences
    Year: 2022
    Book: 21, Part 1
    Pages: 1-15
  • Bioremediation of Surfactants by Bacteria Isolated from Spume Used to Scavenge Surfactants Along with Dyes in Washing Textile Effluents
    Author: DRD Nishi Jayesh Patel
    Journal: JETIR Research Journal
    Year: 2020
    Volume: 7
    Issue: 6
    Pages: 1147-1153

 

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award

Prof Dr Katsunori Nonogaki | Neuroscience | Best Researcher Award šŸ†

Division of Diabetes and Nutrition at RARiS, Tohoku University,Ā Japan
šŸŽ“

Dr. Katsunori Nonogaki is a distinguished professor and clinical specialist in diabetes and internal medicine, holding extensive expertise in lifestyle medicine and diabetes research. He obtained his MD in Japan in 1987, followed by a PhD from Nagoya University Graduate School of Medicine in 1993. His postdoctoral training included positions at UCSF and The Scripps Research Institute, where he focused on metabolism and neuropharmacology. Dr. Nonogaki has held key academic roles at prestigious institutions, including the University of Tokyo and Tohoku University, where he has been a professor since 2008.

Professional ProfileĀ 

šŸ“š Work Experience & Teaching

Dr. Nonogaki has a long-standing academic career, beginning as a lecturer at the University of Tokyo before joining Tohoku University in various professorial roles. His teaching experience spans undergraduate to postgraduate levels, where he mentors future leaders in diabetes research and metabolic health.

šŸŽ–ļø Skills, Awards, and Honors

Dr. Nonogaki is highly skilled in molecular nutrition, metabolic diseases, and translational research. He has served as the Chief of the Laboratory of Molecular Nutrition and is recognized for his contributions to diabetes research, earning several awards in this domain. He has also made impactful contributions to scientific literature, serving on the editorial boards of key journals such as Frontiers in Endocrinology and Diabetes Research and Clinical Practice.

🌐 Memberships & Professional Involvement

His professional involvement extends to numerous editorial roles, including Topic Editor and Associate Editor in leading journals. Dr. Nonogaki is a highly regarded member of the international diabetes research community, where he actively contributes to advancements in metabolic health and diabetes management.

Research Focus

Xiaofeng’s research is centered on entrepreneurial behavior, project selection, and risk assessment. He has proposed a three-stage theory for project selection and developed a dynamic measurement model for entrepreneurial risks. His work has practical implications, particularly in the evaluation of risks in family farms and entrepreneurship education. His 65 published journal articles and various patents further underscore his contributions to the field.

 

Publications :Ā 

“The GLP-1 Receptor Agonist Liraglutide Decreases Primary Bile Acids and Serotonin in the Colon Independently of Feeding in Mice”
Year: 2024
Journal: International Journal of Molecular Sciences

Dr Alexandros Kanellopoulos | Neuroscience | Best Researcher Award

Dr Alexandros Kanellopoulos Neuroscience | Best ResearcherAwardĀ  šŸ†

Principal Scientist of Cognitive Health atĀ DSM-Firmenich, RD Innovation
SwitzerlandšŸŽ“

Alexandros Kanellopoulos is a seasoned Innovation Leader, Principal Scientist, and Clinical Director with over 20 years of expertise in Neuroscience, Metabolism, Early Life Nutrition (ELN), and Medical Nutrition. He has successfully led multidisciplinary teams, pioneered product innovations, and authored more than 20 high-impact publications. With 7 patents to his name, Alexandros excels in transforming scientific research into tangible solutions that meet market needs.

Professional ProfileĀ 

Education

Alexandros Kanellopoulos holds a Ph.D. in Neuroscience from Kapodistrian University, Greece (2008-2013), where his research focused on neurodevelopmental disorders. Prior to this, he completed his M.Sc. in Molecular Medicine (Neuroscience) at the same university (2005-2007), gaining advanced expertise in neuroscience and molecular biology. His academic foundation was established with a B.Sc. in Molecular Biology and Genetics from Dimocritus University of Thrace, Greece (2000-2005), where he developed a strong background in genetics and molecular biology.

Work Experience

In his current role as Global Principal Scientist & Clinical Director at DSM-Firmenich (2023-Present), Alexandros oversees scientific activities, driving innovation in dietary supplements and medical nutrition. Prior to this, he worked as an R&D Innovation Scientist and Project Manager at Nestle SA (2022-2023), leading the development of brain health products for Early Life Nutrition. In 2023, he also held the position of Medical, Scientific & Regulatory Affairs Manager at Nestle Nutrition, focusing on market communication and regulatory compliance. Alexandros previously served as Group Leader, Early Life Brain Metabolism at the University of Lausanne (2020-2022) and as Senior Scientist in Early Life Neuroscience (2016-2020), where he pioneered research in neurodevelopmental disorders.

SkillsĀ 

Alexandros is highly skilled in Innovation & Product Development, leading projects from concept to market. He is an expert in Clinical Research & Protocol Design, managing complex preclinical and clinical trials. His ability to lead multidisciplinary teams and drive Cross-functional Collaboration is complemented by his talent for Stakeholder Engagement & Market Alignment, ensuring alignment between research innovations and market needs. His Strategic Thinking, Problem-solving, and Emotional Intelligence are key to his success in high-impact research and business projects.

Awards & Honors

Throughout his career, Alexandros has earned more than 15 research awards, securing CHF 2.5 million in research funding. He has been awarded 7 patents as an inventor, reflecting his contributions to innovation in neuroscience and nutrition. In addition, he has delivered over 40 invited presentations at international conferences, establishing himself as a respected thought leader in his field.

Ā MembershipĀ 

Alexandros contributes to the scientific community as a Reviewer for leading neuroscience journals and serves as an Editor in scientific publications, ensuring the dissemination of high-quality research.

Teaching Experience

Alexandros is also an experienced educator, having delivered lectures in Neuroscience and Medical Sciences at the University of Lausanne and Kapodistrian University, Athens. In his academic roles, he has mentored over 20 junior scientists, fostering the next generation of researchers and innovators.

Research Focus

Alexandros’ research centers on Early Life Nutrition and its role in brain development. He is particularly focused on Neurodevelopmental Disorders such as Autism and Fragile X Syndrome. His work on Brain Energy Metabolism and Mitochondrial Function provides insights into neurotransmission and social behavior. Alexandros has also designed Preclinical and Clinical Research aimed at developing nutritional solutions to address these complex medical challenges.

Publications :Ā 

  • Activation of the 5-HT1A Receptor by Eltoprazine Restores Mitochondrial and Motor Deficits in a Drosophila Model of Fragile X Syndrome
    🧠 International Journal of Molecular Sciences – 2024
    DOI: 10.3390/ijms25168787
  • Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits
    🧬 Cell – 2020
    DOI: 10.1016/j.cell.2020.02.044
  • Conserved Tao Kinase Activity Regulates Dendritic Arborization, Cytoskeletal Dynamics, and Sensory Function in Drosophila
    šŸ”¬ The Journal of Neuroscience – 2020
    DOI: 10.1523/jneurosci.1846-19.2020
  • Domain-Specific Cognitive Impairments in Humans and Flies With Reduced CYFIP1 Dosage
    🧩 Biological Psychiatry – 2019
    DOI: 10.1016/j.biopsych.2019.04.008
  • SynGO: An Evidence-Based, Expert-Curated Knowledge Base for the Synapse
    🧠 Neuron – 2019
    DOI: 10.1016/j.neuron.2019.05.002
  • Mitochondrial Dysfunction in Autism Spectrum Disorder: Clinical Features and Perspectives
    🧠 Current Opinion in Neurobiology – 2017
    DOI: 10.1016/j.conb.2017.05.018
  • Autism Spectrum Disorders: Translating Human Deficits into Mouse Behavior
    🐁 Neurobiology of Learning and Memory – 2015
    DOI: 10.1016/j.nlm.2015.07.013
  • Learning and Behavioral Deficits Associated with the Absence of the Fragile X Mental Retardation Protein: What a Fly and Mouse Model Can Teach Us
    🧠 Learning & Memory (Cold Spring Harbor, N.Y.) – 2014
    DOI: 10.1101/lm.035956.114
  • Learning and Memory Deficits Resulting from Reduction of the Fragile X Mental Retardation Protein: A Metabotropic Glutamate Receptor-Mediated Inhibition of cAMP Signaling in Drosophila
    🧠 The Journal of Neuroscience – 2012
    DOI: 10.1523/JNEUROSCI.1347-12.2012
  • Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-blind, Placebo-controlled Study
    šŸ’Š The American Journal of Gastroenterology – 2011
    DOI: 10.1038/ajg.2011.179

Dr Andreu Massot TarrĆŗs | Neuroscience | Best Researcher Award

Dr Andreu Massot TarrĆŗs | Neuroscience | Best Researcher Award šŸ†

Neurologist at Hospital Universitari MĆŗtua Terrassa, SpainšŸŽ“

Andreu Massot TarrĆŗs, MD, PhD, is a highly accomplished neurologist and epileptologist with over 20 years of experience. He earned his Medical Doctorate from the Universitat Autònoma de Barcelona in 2003 and later completed a PhD Cum Laude in Medicine, focusing on intracranial atherostenosis. He has held senior neurology positions at prestigious hospitals in Spain, including Hospital Universitari Vall d’Hebron, JimĆ©nez DĆ­az Foundation, and Hospital Universitari MĆŗtua Terrassa, where he currently serves. Dr. Massot TarrĆŗs has specialized expertise in epilepsy, EEG, and cerebrovascular diseases and has completed advanced fellowships in Canada and the UK.

Professional ProfileĀ 

Education

Andreu Massot TarrĆŗs earned his Medical Doctorate in August 2003 from the Universitat Autònoma de Barcelona. He went on to complete his Neurology specialization in May 2009 at the Hospital Universitari Vall d’Hebron, Barcelona. In June 2013, he was awarded a PhD Cum Laude in Medicine by the same university for his thesis on intracranial atherostenosis, supervised by Dr. Montaner Villalonga and Dr. Ɓlvarez-SabĆ­n. His commitment to epilepsy research led him to a Clinical and Research Fellowship in Epilepsy and EEG at Western University, Ontario, in 2014, followed by a Master in Epilepsy from the Universidad de Murcia in 2018, where he received an excellent qualification.

Ā Work Experience

Dr. Massot TarrĆŗs’s medical career has spanned several prestigious institutions. Starting as a clinical observer in London (2008), he then became a Senior Neurologist in Barcelona and Madrid, working in the Neurovascular Unit at Vall d’Hebron (2009-2010) and the Epilepsy Unit at the JimĆ©nez DĆ­az Foundation (2010-2011). Between 2011 and 2021, he took on various senior roles, including at Hospital del Mar and Hospital Universitario Gregorio Marañón, Madrid. Since September 2021, he has been a Senior Neurologist and Epileptologist at Hospital Universitari MĆŗtua Terrassa, where he continues to excel in treating neurological disorders, particularly epilepsy.

Ā SkillsĀ 

Dr. Massot TarrĆŗs is highly skilled in Electroencephalography (EEG) and Video-EEG monitoring. He has extensive experience in intraoperative electrocorticography, cortical stimulation mapping, and the Wada test. His expertise in cerebrovascular diseases and ultrasonography diagnostics has made him a leading lecturer at several top hospitals, including Vall d’Hebron, Hospital del Mar, and Hospital Gregorio Marañón.

Awards & Honors

He holds certifications in Electroencephalography from both the Canadian Society of Clinical Neurophysiology (2015) and the Spanish Society of Neurology (2016). He was also awarded a Cum Laude distinction for his doctoral work and has participated in advanced training like the NIH Stroke Scale Training by the National Stroke Association.

Ā MembershipĀ 

Dr. Massot TarrĆŗs is an active member of the Spanish Society of Neurology and has contributed significantly to clinical neurophysiology through his memberships in various international medical bodies.

Ā Teaching Experience

Dr. Massot Tarrús has shared his knowledge extensively, offering lectures on epilepsy, neurovascular diseases, and ultrasonography techniques. He has taught at institutions like Jiménez Díaz Foundation, Hospital del Mar, and Western University, where his work in EEG and cerebrovascular illness has helped shape the careers of future neurologists.

Ā Research Focus

His research primarily focuses on epilepsy and ischemic cerebrovascular diseases. His PhD thesis, which examined markers of recurrence in intracranial atherostenosis, highlights his dedication to improving diagnostics and treatment outcomes in neurology. He continues to contribute to research on epilepsy and cerebrovascular conditions, aiming to reduce the recurrence of ischemic events in patients.

 

šŸ“–Publications :Ā 

  • šŸ“„ “Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsia Open
    Year: 2023
    Volume: 8(3), pp. 918–929
  • šŸ“Š “Risk factors for comorbid epilepsy in patients with psychogenic non-epileptic seizures. Dataset of a large cohort study”
    Author: Massot-TarrĆŗs, A.
    Journal: Data in Brief
    Year: 2022
    Volume: 45, 108568
  • 🧠 “Roles of fMRI and Wada tests in the presurgical evaluation of language functions in temporal lobe epilepsy”
    Author: Massot-TarrĆŗs, A.
    Journal: Frontiers in Neurology
    Year: 2022
    Volume: 13, 884730
  • šŸ’Š “Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice”
    Co-author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108836
  • šŸ“ˆ “Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures: A large cohort study”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2022
    Volume: 134, 108780
  • 🧩 “Cortical myoclonus associated with coeliac disease showing a characteristic EEG pattern: A case report”
    Author: Massot-TarrĆŗs, A.
    Journal: Seizure
    Year: 2022
    Volume: 95, pp. 81–83
  • šŸš‘ “Response to anakinra in new-onset refractory status epilepticus: A clinical case”
    Author: Massot-TarrĆŗs, A.
    Journal: Seizure
    Year: 2022
    Volume: 94, pp. 92–94
  • 🦠 “Neurological complications of COVID-19 in hospitalized patients: The registry of a neurology department in the first wave of the pandemic”
    Co-author: Massot-TarrĆŗs, A.
    Journal: European Journal of Neurology
    Year: 2021
    Volume: 28(10), pp. 3339–3347
  • šŸ“‰ “Predicting outcome of patients with psychogenic nonepileptic seizures after diagnosis in an epilepsy monitoring unit”
    Author: Massot-TarrĆŗs, A.
    Journal: Epilepsy and Behavior
    Year: 2021
    Volume: 120, 108004
  • 🧬 “E200K familial Creutzfeldt-Jakob disease. MRI, EEG, PET and neuropathological correlation in a family”
    Co-author: Massot-TarrĆŗs, A.
    Journal: Neurologia
    Year: 2021
    Volume: 36(5), pp. 399–401